Related Experiment Video
Updated: Jan 9, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Skin manifestations in individuals with undiagnosed celiac seropositivity: a cross-sectional study
Nina Alicia Pilebo Hagerup1, Selma Flora Nordqvist1, Signe Ulfbeck Schovsbo1
1Center for Clinical Research and Prevention, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Copenhagen, Denmark.
Background:
Celiac disease (CD) is an underdiagnosed disease with a significant diagnostic delay. Previous studies have shown associations between CD and several skin diseases.
Objective:
The objective of this article was to investigate the association between undiagnosed celiac seropositivity and prevalence of self-reported skin symptoms and diseases in adults.
Methods:
In a Danish population-based cohort comprising 9656 participants, we identified individuals with undiagnosed celiac seropositivity, defined by celiac antibody positivity against immunoglobulin (Ig) A and/or IgG tissue transglutaminase (TTG) ≥7 U/mL and/or IgG deamidated gliadin peptide ≥10 U/mL, without a known diagnosis of CD in the National Patient Register. Information on skin symptoms and diseases were obtained from participant-completed questionnaires. The associations between skin symptoms and diseases and undiagnosed celiac seropositivity were analyzed by ꭓ2 or Fisher's exact test and logistic regression were used to calculate odds ratios (OR) with 95% confidence intervals (CI).
Results:
We excluded 13 participants with a previous CD diagnosis and 386 participants due to missing measurements of CD antibodies, resulting in a study population of 9257 participants. In this population, 0.76% (70/9257) had undiagnosed celiac seropositivity. There were no statistically significant differences in skin symptoms and diseases between participants with and without undiagnosed celiac seropositivity; the OR for any skin symptom or disease was 0.83 (95% CI: 0.41-1.67) among individuals with undiagnosed celiac seropositivity compared with individuals without.
Conclusion:
In this cross-sectional study, we found no differences in self-reported skin symptoms and diseases between participants with and without undiagnosed celiac seropositivity.
Related Concept Videos
Other Disorders of Digestive System
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

